HC Wainwright Has Negative Outlook for RCUS Q2 Earnings
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Analysts at HC Wainwright dropped their Q2 2025 earnings estimates for Arcus Biosciences in a research report issued on Wednesday, May 7th. HC Wainwright analyst E. Bodnar now anticipates that the company will post earnings per share of ($1.19) for the quarter, down from their previous estimate […]
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Analysts at HC Wainwright dropped their Q2 2025 earnings estimates for Arcus Biosciences in a research report issued on Wednesday, May 7th. HC Wainwright analyst E. Bodnar now anticipates that the company will post earnings per share of ($1.19) for the quarter, down from their previous estimate […]
